Industry & ReformNews
Public health buffeted by free-trade winds
Australia's pharmaceutical benefits scheme is being challenged by lobbying from US industry, writes Patricia Ranald.
Please login below to view content or subscribe now.
Australia's pharmaceutical benefits scheme is being challenged by lobbying from US industry, writes Patricia Ranald.
Please login below to view content or subscribe now.
